These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 2508586

  • 1. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA, Cumbo TJ, Nix DE, Sands MF, Schentag JJ.
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis.
    Lipman J, Allworth A, Wallis SC.
    Clin Infect Dis; 2000 Nov; 31(5):1131-3. PubMed ID: 11073740
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
    Pedersen SS.
    Scand J Infect Dis Suppl; 1989 Nov; 60():89-97. PubMed ID: 2667111
    [Abstract] [Full Text] [Related]

  • 6. Ciprofloxacin: an update on clinical experience.
    Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R.
    Am J Med; 1987 Apr 27; 82(4A):381-6. PubMed ID: 3555063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 27; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 10. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM, Davis NB, Wu SC, Kahn J.
    Curr Med Res Opin; 2006 May 27; 22(5):843-50. PubMed ID: 16709306
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E, Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.
    Clin Microbiol Infect; 2005 Sep 27; 11(9):690-703. PubMed ID: 16104983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Ciprofloxacin in the treatment of hospital-acquired pneumonia: a surveillance study in 676 patients].
    Kljucar S, Rost KL, Landen H.
    Pneumologie; 2002 Oct 27; 56(10):599-604. PubMed ID: 12375221
    [Abstract] [Full Text] [Related]

  • 17. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL, Berenson CS, Greco TP, Mangi RJ, Sims M, Thornton GF, Andriole VT.
    Am J Med; 1987 Apr 27; 82(4A):303-6. PubMed ID: 3555052
    [Abstract] [Full Text] [Related]

  • 18. Ciprofloxacin therapy in cystic fibrosis.
    Scully BE, Nakatomi M, Ores C, Davidson S, Neu HC.
    Am J Med; 1987 Apr 27; 82(4A):196-201. PubMed ID: 3555036
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.